KLX 171 (Fenofibrate 160 mg)

Pill imprint KLX 171 has been identified as Fenofibrate 160 mg.

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iv, elevated vldl (and more), and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 160 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for KLX 171

Fenofibrate 160 mg KLX 171
Fenofibrate 160 mg KLX 171
Fenofibrate
Imprint:
KLX
171
Strength:
160 mg
Color:
White
Size:
12.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Fibric acid derivatives
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Karalex Pharma
National Drug Code (NDC):
42043-0171
Inactive Ingredients:
betadex
silicon dioxide
calcium phosphate dihydrate dibasic
docusate sodium
sodium benzoate
hypromellose
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polysorbate 80
sodium starch glycolate type A potato
titanium dioxide

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)